Comerica Bank
CRBP icon

Comerica Bank’s Corbus Pharmaceuticals CRBP Stock Holding History

Comerica Bank’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.63M Hold
200,001
– – 0.01% 1223
2025
Q3 		$2.53M Hold
200,001
– – 0.01% 1044
2025
Q2 		$1.38M Hold
200,001
– – 0.01% 1344
2025
Q1 		$1.06M Buy
200,001
+200,000
+20,000,000% +$1.77M ﹤0.01% 1469
2024
Q4 		$12 Hold
1
– – ﹤0.01% 3670
2024
Q3 		$21 Hold
1
– – ﹤0.01% 3664
2024
Q2 		$45 Hold
1
– – ﹤0.01% 3686
2024
Q1 		$39 Hold
1
– – ﹤0.01% 3729
2023
Q4 		$6 Hold
1
– – ﹤0.01% 3726
2023
Q3 		$7 Buy
+1
New +$7 ﹤0.01% 3787

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank's CRBP Position: Q4 2025 in Review

Comerica Bank held its Corbus Pharmaceuticals (CRBP) position steady in Q4 2025 at 200,001 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #1223.

Comerica Bank first reported a position in CRBP in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.53M in Q3 2025. 100 funds tracked by Wall St. Rank hold CRBP as of Q4 2025.

  • Comerica Bank held 200,001 shares of Corbus Pharmaceuticals worth $1.63M as of Q4 2025.
  • Comerica Bank left its Corbus Pharmaceuticals share count unchanged in Q4 2025.
  • Corbus Pharmaceuticals made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1223 holding.
  • Comerica Bank first reported a position in Corbus Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • Comerica Bank's Corbus Pharmaceuticals position peaked at $2.53M in Q3 2025.
  • 100 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.